Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.60 |
| ▸ | CA1 | P00915 | 5/20 | 0.60 |
| ▸ | CA2 | P00918 | 5/20 | 0.60 |
| ▸ | CA9 | Q16790 | 5/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.55 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | SUCNR1 | Q9BXA5 | 3/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31606699 | 0.90 | CA1 (0.54) | CA12CA1CA2CA9L3MBTL1 | |
| SCHEMBL21430480 | 0.89 | CA1 (0.59) | CA12CA1CA2CA9ITGB3 | |
| SCHEMBL31108265 | 0.89 | CA1 (0.55) | CA12CA1CA2CA9L3MBTL1 | |
| SCHEMBL15391900 | 0.87 | CA12 (0.63) | CA12CA1CA2CA9L3MBTL1 | |
| SCHEMBL13907700 | 0.87 | ALDH1A1 (0.68) | CA12CA1CA2CA9L3MBTL1 | |
| SCHEMBL926118 | 0.87 | CA12 (0.63) | CA12CA1CA2CA9L3MBTL1 | |
| SCHEMBL4498509 | 0.86 | CA2 (0.57) | CA1CA2FFAR1KMT2AMAPT | |
| SCHEMBL30521147 | 0.85 | CA1 (0.60) | CA12CA1CA2CA9FFAR1 | |
| SCHEMBL21430470 | 0.85 | CA12 (0.58) | CA12CA1CA2CA9L3MBTL1 | |
| Hydrochloric Acid SCHEMBL21410052 | 0.84 | CA12 (0.57) | CA12CA1CA2CA9L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658667-A1 | CYCLIC PEPTIDES FOR INHIBITING TNF RECEPTOR 1 ACTIVITY | Merck Sharp & Dohme LLC (US) | 2025-12-10 | — | — | EP | disclosed |
| CN-119684280-A | Targeting protein arginine methylation proximity-induced small molecule chimeric platform MeTAG and application thereof | 西安交通大学医学院第一附属医院 | 2025-03-25 | — | — | CN | disclosed |
| WO-2024163691-A1 | CYCLIC PEPTIDES FOR INHIBITING TNF RECEPTOR 1 ACTIVITY | MERCK SHARP & DOHME LLC (US) | 2024-08-08 | — | — | WO | disclosed |
| US-20190343873-A1 | SEQUENCE-SELECTIVE GENE EXPRESSION REGULATORS | KYOTO UNIVERSITY (JP) | 2019-11-14 | — | — | US | disclosed |
| US-20190343873-A1 | SEQUENCE-SELECTIVE GENE EXPRESSION REGULATORS | KYOTO UNIVERSITY (JP) | 2019-11-14 | — | — | US | disclosed |
| WO-2019189419-A1 | ANTI-CANCER AGENT-BONDED ALGINIC ACID DERIVATIVE | 持田製薬株式会社 | 2019-10-03 | — | — | WO | disclosed |
| US-5977124-A | β-adrenergic agonists | PFIZER INC. (US) | 1999-11-02 | — | — | US | disclosed |
| EP-0828712-A1 | BETA-ADRENERGIC AGONISTS | PFIZER INC. (US) | 1998-03-18 | — | — | EP | disclosed |
| EP-0824519-A1 | BETA-ADRENERGIC AGONISTS | PFIZER INC. (US) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996035671-A1 | β-ADRENERGIC AGONISTS | PFIZER INC. (US) | 1996-11-14 | — | — | WO | disclosed |
| WO-1996035670-A1 | β-ADRENERGIC AGONISTS | PFIZER INC. (US) | 1996-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190343873-A1 | SEQUENCE-SELECTIVE GENE EXPRESSION REGULATORS | BRDT, BRPF3, BAZ2A | CA12 2418/4885CA1 2126/4885CA2 4032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.